TY - JOUR
T1 - Inverse association between adiponectin and C-reactive protein in substantially healthy Japanese men
AU - Matsushita, Kunihiro
AU - Yatsuya, Hiroshi
AU - Tamakoshi, Koji
AU - Wada, Keiko
AU - Otsuka, Rei
AU - Zhang, Huiming
AU - Sugiura, Kaichiro
AU - Kondo, Takahisa
AU - Murohara, Toyoaki
AU - Toyoshima, Hideaki
N1 - Funding Information:
The authors wish to express their sincere appreciation to the study participants and to the healthcare personnel of the local government office. This work was supported by Grants 13470087 (H.T.), 15689011 (H.Y.), and 16590499 (K.T.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the Japan Atherosclerosis Prevention Fund (JAPF).
PY - 2006/9
Y1 - 2006/9
N2 - Objective: An inverse association between adiponectin and C-reactive protein (CRP) has been shown in certain pathological states including obesity, diabetes, and coronary artery disease, which themselves might have confounded this association. This study investigated the association between adiponectin and CRP among substantially healthy subjects. Methods and results: A population of 2347 middle-aged Japanese men with no medical history of cardiovascular disease, cancer, diabetes, hypertension, or hyperlipidemia was evaluated. Those with some metabolic syndrome components from serological and anthropometric tests were excluded, leaving 714 men for analysis. Serum adiponectin and CRP were significantly correlated (r = -0.21, P < 0.001). After categorization into quartiles from the lowest to the highest adiponectin concentration (Q1 to Q4), the CRP level was found to be significantly higher in Q1 than in Q2, Q3 and Q4 (0.41 mg/L versus 0.30, 0.25 and 0.24 mg/L, P = 0.043, P < 0.001 and P < 0.001, respectively). These associations remained significant even after adjustment for covariates. Moreover, multiple linear regression analysis revealed that adiponectin contributed more strongly to CRP than other factors, including the index of insulin resistance. Conclusions: An inverse and strong association between adiponectin and CRP in substantially healthy subjects implies that decreased serum adiponectin might be fundamentally associated with the early stage of low-grade inflammation.
AB - Objective: An inverse association between adiponectin and C-reactive protein (CRP) has been shown in certain pathological states including obesity, diabetes, and coronary artery disease, which themselves might have confounded this association. This study investigated the association between adiponectin and CRP among substantially healthy subjects. Methods and results: A population of 2347 middle-aged Japanese men with no medical history of cardiovascular disease, cancer, diabetes, hypertension, or hyperlipidemia was evaluated. Those with some metabolic syndrome components from serological and anthropometric tests were excluded, leaving 714 men for analysis. Serum adiponectin and CRP were significantly correlated (r = -0.21, P < 0.001). After categorization into quartiles from the lowest to the highest adiponectin concentration (Q1 to Q4), the CRP level was found to be significantly higher in Q1 than in Q2, Q3 and Q4 (0.41 mg/L versus 0.30, 0.25 and 0.24 mg/L, P = 0.043, P < 0.001 and P < 0.001, respectively). These associations remained significant even after adjustment for covariates. Moreover, multiple linear regression analysis revealed that adiponectin contributed more strongly to CRP than other factors, including the index of insulin resistance. Conclusions: An inverse and strong association between adiponectin and CRP in substantially healthy subjects implies that decreased serum adiponectin might be fundamentally associated with the early stage of low-grade inflammation.
KW - Adiponectin
KW - C-reactive protein
KW - Cardiovascular disease
KW - Insulin resistance
KW - Metabolic syndrome
UR - http://www.scopus.com/inward/record.url?scp=33746561419&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33746561419&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2005.10.031
DO - 10.1016/j.atherosclerosis.2005.10.031
M3 - Article
C2 - 16325822
AN - SCOPUS:33746561419
SN - 0021-9150
VL - 188
SP - 184
EP - 189
JO - Atherosclerosis
JF - Atherosclerosis
IS - 1
ER -